SANTA FE, N.M., Dec. 12, 2012 /PRNewswire/ -- Sigma Labs, Inc. (OTCBB: SGLB) announced today that it has expanded and enhanced its intellectual property and patent portfolio. Sigma Labs was recently awarded a patent involving the monitoring and control of fusion processes including those found in Additive Metal Manufacturing (AMM) and 3D printing. Mark Cola, President and Chief Executive Officer of Sigma Labs, stated that "this AMM-related patent will allow us to better position our PrintRite3D™ series of hardware and software products for additive metal manufacturing and 3D printing."
Sigma Labs also filed an international patent application protecting its biomedical technology for treating medical implants so as to promote protein adsorption and osseointegration, a process that results in the direct anchorage of an implant to the surrounding bone. Furthermore, the results of recent tests completed at Sandia National Laboratories appear to indicate that specially treated implants with Sigma Labs' patent-pending technology show an increase in the ability of proteins to bind to the implant surfaces as compared to untreated baseline implants. Vivek Dave, Executive Vice President for Business Development at Sigma Labs stated that, "we feel that this international patent filing will ensure our ability to provide industry-leading, competitive products and services for several biomedical prosthetic fields."
Mr. Cola added that, "the company currently is exploring the formation of joint venture relationships where appropriate." There can be no assurance, however, that Sigma Labs will enter into any joint ventures.
About Sigma Labs, Inc.
Sigma Labs, Inc. has three wholly-owned subsidiaries – B6 Sigma, Inc., Sumner & Lawrence Limited (dba Sumner Associates) and La Mancha Company. B6 Sigma develops advanced manufacturing solutions and materials technologies, as well as R&D solutions for first-tier integrators and other commercial firms worldwide. Sumner Associates and La Mancha provide high-level consultants to Federal government and commercial clients seeking productive solutions for emerging and strategic development technologies. Sigma Labs has current contracts with Federal government and private industry clients to provide high-level consultants and develop technologies from their conception through the design, building, and testing of prototype systems. For more information please visit us at www.sigmalabsinc.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often contain words such as "expects," "anticipates," "intends," "believes" or "will." Our forward-looking statements are subject to a number of risks, uncertainties and assumptions that could adversely affect us, including the risks set forth in our most recent annual report on Form 10-K. The forward-looking statements in this press release are made only as of the date of this press release. We undertake no obligation to update our forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE Sigma Labs, Inc.